Summary
Industry
Insights
Automata, based in London, focuses on automating workflows within the life sciences sector. By replacing manual processes and non-specialized software tools with robust automation solutions, Automata addresses inefficiencies and high error rates that can hinder research and development. Leveraging advanced machine learning algorithms, the platform is tailored to meet the unique needs of life sciences organizations, potentially improving accuracy and operational speed. Supported by a strong group of investors, Automata is well-positioned to capitalize on the growing demand for specialized automation in health tech, addressing a crucial market gap.
Investors
Local Globe Seed
ABB Technology Ventures Seed
HCVC Series B
Hummingbird Ventures Series B
Latitude Series B
Octopus Ventures Series B
Aldea VC Series B
Isomer Capital Series B
A.P. Moller Holding Series B
Dimension Series B
Entrepreneur First Series A
Firstminute Capital Series A